通过T细胞受体疗法治疗固体瘤的综合解决方案:一篇评论
Peiwen Ma1, Yale Jiang1, Guo Zhao1
1Clinical Trial Center, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
European journal of cancer (Oxford, England : 1990)
|July 27, 2024
概括
T细胞受体治疗 (TCR-T) 对黑色素瘤等固体瘤显示出前景. 本综述详细介绍了TCR-T的开发考虑因素,重点关注狂热性,抗原选择以及改善疗效的未来方向.
科学领域:
- 免疫治疗是一种免疫疗法.
- 在瘤学瘤学.
- 细胞疗法细胞疗法
背景情况:
- T细胞受体治疗 (TCR-T) 在特定固体瘤中显示出显著的疗效,耐用性和安全性.
- 现有的研究突出显示了与人乳头瘤病毒相关的瘤,突肉瘤和黑色素瘤的成功.
研究的目的:
- 为专门针对固体瘤开发TCR-T疗法提供全面考虑.
- 审查当前的临床应用,优势和影响TCR-T在固体瘤中的疗效和安全性的关键参数.
主要方法:
- 对TCR-T临床应用和方法的当前文献的综述.
- 探讨有效性/安全性参数:狂热度,药理动力学/药理动力学和适应症.
- 研究影响T细胞受体激发的因素:抗原选择,获取,优化和共受体参与.
- 使用RNA-seq数据集对瘤抗原表达的分析,以更广泛地覆盖固体瘤.
主要成果:
- 在特定的固体瘤类型中,TCR-T疗法显示出潜在的益处.
- 敏性,药理动力学/药理动力学和抗原选择对于TCR-T在固体瘤中的成功至关重要.
- 对RNA-seq数据的分析表明,有机会在各种固体瘤中扩大TCR-T覆盖范围.
结论:
- 仔细考虑抗原选择,T细胞受体热度和药理动力学/药理动力学特征对于在固体瘤中成功开发TCR-T至关重要.
- 对优化TCR-T策略和探索新瘤抗原的进一步研究对于推进这种疗法至关重要.
- 在治疗更广泛的固体瘤方面,TCR-T具有显著的前景,并改善了治疗结果.
更多相关视频
09:12Author Spotlight: Advancements in Hypoxia-Sensitive CAR-T Therapy for Enhanced Cancer Immunotherapy
Published on: June 14, 2024
874
09:53Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens
Published on: February 6, 2017
11.4K
相关概念视频
01:27Tumor Immunotherapy
498
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
498
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
01:30Cancer Vaccines
347
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
347
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K